iShares Biotechnology ETF
IBB
iShares Biotechnology ETF IBB Strategy
The investment seeks to track the investment results of the NYSE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector.
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
ETFs News & Analysis
etfs
Is this the best emerging market ETF on the ASX?
An alternative approach to the emerging market space.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,080.70 | 39.80 | -0.44% |
| CAC 40 | 7,759.44 | 24.60 | 0.32% |
| DAX 40 | 23,681.27 | 125.86 | -0.53% |
| Dow JONES (US) | 45,553.31 | 38.36 | 0.08% |
| FTSE 100 | 9,239.85 | 18.41 | 0.20% |
| HKSE | 25,938.13 | 304.22 | 1.19% |
| NASDAQ | 21,818.71 | 20.01 | 0.09% |
| Nikkei 225 | 43,459.29 | 184.52 | -0.42% |
| NZX 50 Index | 13,253.73 | 27.41 | -0.21% |
| S&P 500 | 6,500.58 | 5.43 | 0.08% |
| S&P/ASX 200 | 8,803.50 | 37.40 | -0.42% |
| SSE Composite Index | 3,807.29 | 19.55 | -0.51% |